Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2009-09-17
2010-11-23
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C530S300000
Reexamination Certificate
active
07838005
ABSTRACT:
Disclosed are a method of for treating insulin resistance and a method identifying a compound for treating insulin resistance.
REFERENCES:
patent: 5847008 (1998-12-01), Doebber et al.
patent: 6090839 (2000-07-01), Adams et al.
patent: 6287859 (2001-09-01), DeWeille et al.
patent: 6635432 (2003-10-01), Welsh et al.
patent: 6727260 (2004-04-01), Varming et al.
patent: 2006/0234242 (2006-10-01), Cheatham et al.
patent: 2007/0281986 (2007-12-01), Collier et al.
An et al., “Genome-wide Linkage Scans for the Fasting Glucose, Insulin, and Insulin Resistance in the National Heart, Lung , and Blood Institute Family Blood Pressure Program,”Diabetes, 54:909-914 (2005).
Chen et al., “A Role for ASIC3 in the Modulation of High-Intensity Pain Stimuli,”PNAS, 99(13):8992-8997 (2002).
Diochot et al., “A New Sea Anemone Peptide, APETx2, Inhibits ASIC3, a Major Acid-Sensitive Channel in Sensory Neurons,”The EMBO Journal, 23:1516-1525 (2004).
Voilley et al., “Nonsteroid Anti-Inflammatory Drugs Inhibit Both the Activity and the Inflammation-Induced Expression of Acid-Sensing Ion Channels in Nociceptors,”The Journal of Neuroscience, 21(20):8026-8033 (2001).
Voilley, N., “Acid-Sensing Ion Channels (ASICs): New Targets for the Analgesic Effects of Non-Steroid Anti-Inflammatory Drugs (NSAIDs),”Curr. Drug Targets Inflanun. Allergy, 3(1):71-79 (2004).
Yuan et al., “Reversal of Obersity-and-Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption ofIkkβ,” Science, 239:1673-1677 (2001).
Waldmann et al. (JBC 272:20975-20978, 1997).
Kaiser, Science 317, 2007, 580.
Chao et al. (The Mount Sinai J of Medicine, 2004, 305-312).
Scherer et al., (Nat. Biotechnol., 2003, 21(12), pp. 1457-1465).
Mahato et al. (Expert Opinion on Drug Delivery, Jan. 2005, vol. 2, No. 1, pp. 3-28).
Chen Chih-Cheng
Huang Shyh-Jer
Lin Yi-Wen
Academia Sinica
Chandra Gyan
Landsman Robert
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Treatment of insulin resistance by administering an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of insulin resistance by administering an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of insulin resistance by administering an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4232019